ArticleMolecules (Basel, Switzerland)2022

First Discovery of Cholesterol-Lowering Activity of Parthenolide as NPC1L1 Inhibitor.

Wenjing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.